<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>47-PLATELET-AGGREGATION-INHIBITORS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="PLATELET AGGREGATION INHIBITORS" code="B01AC-001" /></DRUG1>
<DRUG2>
<DRUG name="ANAGRELIDE" rxcui="596724">
<ATC code="L01XX3" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of hemorrhagic events 

</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>47-PLATELET-AGGREGATION-INHIBITORS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="PLATELET AGGREGATION INHIBITORS" code="B01AC-001" /></DRUG1>
<DRUG2>
<CLASS name="ORAL ANTICOAGULANTS" code="B01A-001" /></DRUG2>
<DESCRIPTION>Increase of the risk of hemorrhage </DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>47-PLATELET-AGGREGATION-INHIBITORS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="PLATELET AGGREGATION INHIBITORS" code="B01AC-001" /></DRUG1>
<DRUG2>
<DRUG name="DEFIBROTIDE" rxcui="1311089">
<ATC code="B01AX01" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increased risk of hemorrhage</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>47-PLATELET-AGGREGATION-INHIBITORS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="PLATELET AGGREGATION INHIBITORS" code="B01AC-001" /></DRUG1>
<DRUG2>
<CLASS name="HEPARINS" code="B01AB" /></DRUG2>
<DESCRIPTION>Increase of the risk of hemorrhage </DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>47-PLATELET-AGGREGATION-INHIBITORS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="PLATELET AGGREGATION INHIBITORS" code="B01AC-001" /></DRUG1>
<DRUG2>
<CLASS name="THROMBOLYTICS" code="B01AD" /></DRUG2>
<DESCRIPTION>Increase of the risk of hemorrhage</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
</INTERACTIONS>
